Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets
- 1 July 1977
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 44 (2), 179-186
- https://doi.org/10.1016/0014-2999(77)90104-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lungNature, 1976
- The importance of phospholipase-A2 in prostaglandin biosynthesisBiochemical Pharmacology, 1976
- Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleenBritish Journal of Pharmacology, 1973
- The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti‐inflammatory drugsBritish Journal of Pharmacology, 1972
- Indomethacin and Aspirin abolish Prostaglandin Release from the SpleenNature New Biology, 1971
- Prostaglandins released by the SpleenNature, 1968